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Summary 
We have recently shown that lipopolysaccharide (LPS)-binding protein (LBP) is a lipid transfer 
protein that catalyzes two distinct reactions: movement of bacterial LPS (endotoxin) from LPS 
micelles to soluble CD14 (sCD14) and movement of LPS from micelles to reconstituted high 
density lipoprotein (R-HDL) particles.  Here we show that LBP facilitates  a third lipid transfer 
reaction:  movement of LPS from LPS-sCD14 complexes to R-HDL particles.  This action of 
LBP is catalytic, with one molecule of LBP enabling the movement of multiple LPS molecules 
into  R-HDL.  LBP-catalyzed movement of LPS from LPS-sCD14 complexes to R-HDL neu- 
tralizes the capacity of LPS to stimulate polymorphonuclear leukocytes. Our findings show that 
LPS may be transferred to R-HDL either by the direct action of LBP or by a two-step reaction 
in which LPS is first transferred to sCD14 and subsequently to R-HDL  We have observed that 
the two-step pathway of LPS transfer to R-HDL is strongly favored over direct transfer.  Neutral- 
ization  of LPS by LBP and R-HDL was accelerated more than 30-fold by addition of sCD14. 
Several observations suggest that sCD14 accelerates  this reaction by serving as a shuttle for LPS: 
addition of LBP and sCD14 to LPS micelles resulted in LPS-sCD14 complexes that could diffuse 
through  a 100-kD cutoff filter;  LPS-sCD14 complexes appeared transiently during movement 
of LPS to R-HDL facilitated by purified LBP;  and sCD14 could facilitate transfer  of LPS to 
R-HDL without  becoming part  of the  final  LPS-R-HDL complex.  Complexes  of LPS and 
sCD14 were formed transiently when LPS was incubated in plasma, suggesting that these com- 
plexes may play a role as intermediates in the neutralization  of LPS under physiological condi- 
tions. These findings detail a new activity for sCD14 and suggest a novel mechanism for lipid 
transfer by LBP. 
T 
he serum proteins soluble CD14 (sCD14) 1 (1) and LPS- 
binding protein (LBP) (2) play a crucial role in enabling 
responses of cells to gram-negative LPS (endotoxin). We have 
recently found that  CD14 binds LPS stably and with low 
stoichiometry (3),  and that  LPS-sCD14 complexes stimu- 
late cells (3, 4). Spontaneous binding of LPS to CD14 occurs 
very slowly, but the rate of binding is dramatically acceler- 
ated by LBP. In this catalytic reaction,  a single molecule of 
LBP may promote the movement of )100 molecules of LPS 
in 30 min (3). The acceleration of LPS binding to CD14 cata- 
lyzed by LBP may thus explain the increased sensitivity of 
CD14-bearing  cells  to LPS in the presence of LBP (2). 
M. M. Wurfel and E. Hailman made equal contributions to this work. 
1  Abbreviations used in this  paper: apo A-I, apolipoprotein A-I; CETP, cho- 
lesterol ester transfer protein; HDL, high density  lipoproteins; HSA, human 
serum albumin; LBP,  LPS binding protein; NHP, normal human plasma; 
R-HDL, reconstituted HDL particles; sCD14, soluble CD14. 
In whole plasma, LBP may catalyze movement of LPS to 
destinations other than CD14. Lipoprotein particles, such as 
high density lipoproteins (HDL), bind LPS avidly (5, 6), pre- 
sumably because of partitioning of the amphiphilic LPS mol- 
ecule into the phospholipid surface of the lipoprotein. Binding 
of LPS to HDL effectively neutralizes its biological potency 
both in vitro and in vivo (5-7). Recently, reconstituted HDL 
particles (R-HDL) prepared from purified apolipoprotein A-I 
(apo A-I), phosphatidylcholine (PC), and cholesterol have been 
shown to protect from LPS-induced shock, fever, and death 
in animal models of endotoxemia (8, 9). We have found that 
the rate of spontaneous binding of LPS to R-HDL particles 
is negligible, but that LBP accelerates  this rate (10). As with 
the LBP-mediated movement of LPS to CD14, LBP acts cata- 
lytically to promote partitioning  of LPS into R-HDL (10). 
Thus, LBP may catalyze two distinct reactions with oppo- 
site biological effects. It may move LPS to CD14 and initiate 
cellular responses, or it may move LPS to R-HDL where it 
is biologically inert.  Here we describe a third reaction cata- 
lyzed by LBP: movement of LPS from LPS-sCD14 complexes 
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be effective blockers of the response to LPS, even after forma- 
tion  of LPS-sCD14  complexes. 
LBP catalyzes movement of LPS to sCD14 (3) and, as shown 
here, from sCD14 to R-HDL. These two reactions thus re- 
sult in the net movement of LPS into R-HDL. Here we show 
that under defined conditions  this two-step process may be 
far more e~cient  than direct LBP-mediated transfer of LPS 
to R-HDL: addition of sCD14 accelerated the LBP-mediated 
movement of LPS into R-HDL by as much as 100-fold. We 
propose  that  sCD14  accelerates  the  transfer  of LPS  from 
micelles to R-HDL by acting as a carrier or shuttle for LPS 
between  these  two  sites. 
Materials  and Methods 
Reagents.  LPS from Salmonella minnesota strain R60 (Ra) and 
3H-labeled LPS from Escherichia coli LCD25 (K12) were purchased 
from List Biological Laboratories (Campbell, CA). Human serum 
albumin (HSA) was purchased from Armour Pharmaceutical Co. 
(Kankakee,  IL). Recombinant human LBP and sCD14, expressed 
and purified as described (3),  were a generous gift of Dr. Henri 
Lichenstein  (Amgen,  Inc., Thousand  Oaks,  CA). 
Preparation of R-HDL Particles.  R-HDL was prepared by the 
sodium cholate dialysis method, as previously described (11). Briefly, 
apo A-I, purified by sequential ultracentrifugation and size exclu- 
sion chromatography (12), was mixed with egg PC, cholesterol, 
and  cholate  at  a  molar  ratio  of 80:4:1:80  (PC/cholesterol/apo 
A-I/cholate),  and cholate was removed with extensive dialysis against 
PDEDTA (Dulbecco's PBS lacking Ca  2+ and Mg  2§ , with 1 mM 
EDTA), containing 0.01%  sodium azide. Final preparations were 
stored in PDEDTA with 0.01% azide at 4~  All concentration 
values for R-HDL particles are expressed as the equivalent concen- 
tration of apoA-I in micrograms per milliliter. 
Formation of LPS-sCD14 Complexes.  LPS and sCD14, at con- 
centrations 500-fold higher than those stated in each figure, were 
incubated together for 5-18 h at 37~  in APBS (Dulbecco's PBS 
with  Ca  2+  and  Mg  2+,  0.5%  HSA).  These high  concentrations 
were designed to ensure complete binding of LPS to sCD14 as pre- 
viously described (3). 
Stimulation of PMN by LPS.  To assess the biologic activity of 
LPS, we measured adhesion of human PMN to fibrinogen-coated 
surfaces as described (13). In this assay, stimulation of PMN adhe- 
sion is dependent on either the binding of LPS to cell surface CD14 
in the presence of LBP, or exposure to preformed LPS-sCD14 com- 
plexes in the absence of LBP.  Adhesion  of the stimulated PMN 
to fibrinogen is mediated by the leukocyte integrin CD11b/CD18 
(CR3, Mac-l) (13). Briefly, mixtures containing LPS were diluted 
in APBS to the concentrations indicated, yielding a final volume 
of 50 #1. 10/xl of freshly isolated PMN (2  x  107 cells/ml in HAP 
[Dulbecco's PBS with 0.5  U/m1 aprotinin,  0.05%  HSA, 3 mM 
D-glucose])  fluorescently labeled with 5- (and 6-) carboxyfluores- 
cein diacetate succinimidyl ester as described (13), were added and 
incubated for 10 min at 37~  to stimulate the cells.  PMN were 
then  washed  into  HAP  and  added  to  a  72-well  Terasaki  plate 
(Robbins Scientific,  Sunnyvale,  CA) precoated with  fibrinogen. 
After 15 rain at 37~  adherence of PMN to the plate was quanti- 
tared. The fluorescence in each well was measured using a Cytofluor 
2300 (Millipore Corp., Bedford, MA) as a way of quantitating the 
total number of cells per well.  The plate was then washed and 
fluorescence was measured again. Binding is expressed as the per- 
centage of cells remaining in the well after the washing step (adhe- 
sion %). Donor-to-donor variation in maximal responses (25-75% 
adhesion) prohibited averaging results of separate experiments, but 
the pattern of responses was highly reproducible. 
Neutralization of LPS and LPS-sCD14 Complexes.  Neutraliza- 
tion of LPS was measured as the loss of the ability to stimulate 
adhesion of PMN to fibrinogen and was assayed as previously de- 
scribed (10). Briefly, LPS, R-HDL, and variable amounts of CD14 
and LBP were diluted in APBS to a final volume of 50/~1. After 
incubation for the stated time at 37~  the amount of available 
LPS remaining in the tube was assessed by adjusting the LBP con- 
centration,  if necessary,  to 1/~g/ml with 2.5/~1  of concentrated 
LBP, adding fluorescently labeled  PMN and measuring adhesion 
as described above. The neutralization of LPS-sCD14 complexes 
by R-HDL and the effect of LBP on this neutralization was mea- 
sured  in  a  similar  fashion,  but  with  one  difference.  Because 
LPS-sCD14 complexes stimulate cells with no requirement for LBP 
(3), the concentration of LBP was not adjusted to 1/~g/ml before 
the addition of PMN. 
Electrophoresis.  [3H]LPS  was sonicated for 1 rain and incubated 
at 37~  with R-HDL and other proteins, as indicated in the figure 
legends. When [3H]LPS-sCD14 complexes were used,  a preincu- 
bation step was added:  [3H]LPS was sonicated  and incubated with 
sCD14 overnight at 37~  in PDEDTA at concentrations fivefold 
higher than those used in each experiment, then added to samples 
with R-HDL and other proteins at the final concentrations indi- 
cated in the figure legends. Just before electrophoresis, 1/2 vol of 
a loading buffer containing 0.005% bromophenol blue and 20% 
glycerol in PBS or PDEDTA was added to each sample. The samples 
were run in continuous buffer (pH 8.6), nondenaturing Tris-glycine 
polyacrylamide gels (Novex, San Diego, CA) at 100-150 V for 2-3 h 
in a running buffer containing 192 mM glycine,  24 mM Tris, pH 
8.3. After electrophoresis, the gels were fixed in 50% EtOH, 10% 
HAc for 1-18 h, soaked in ENHANCE  TM (Dupont-NEN, Boston, 
MA) for 1 h, washed three times for 15 rain in double-distilled 
H~O,  dried,  and  exposed  to  XAR  film  (Eastman  Kodak  Co., 
Rochester,  NY) for 2 d. 
Movement of  [3H]LPS across lO0-kD Cutoff Filters.  [3HILPS (10 
ng/ml) was diluted in HAP with buffer, rLBP (1 #g/ml), rsCD14 
(1 #g/ml), or rLBP and rsCD14 in a final volume of 500 #1 and 
incubated for 60 rain at 37~  Each solution was then subjected 
to ultra filtration using a Microcon unit (Amicon Corp., Beverly, 
MA) with a 100-kD cutoff membrane. Ultrafiltration was accom- 
plished by centrifugation at 8,000 g, until all the solution had passed 
through the filter. Radioactivity in the ultrafiltrate was evaluated 
by scintillation counting in 3 ml of Ready Safe  TM (Beckman Instru- 
ments, Palo Alto, CA). The movement of LBP and sCD14 across 
the ultrafiltration membrane was assessed by ELISA, as described 
(1,  10). 
Immunoprecipitation ofsCD14.  Immunoprecipitation was used 
to examine the binding of [3H]LPS to sCD14 in plasma. 26ic, an 
mAb that recognizes CD14 without blocking binding of LPS (14), 
and IB4, an mAb directed against the j82-integrin molecule (15), 
were coupled to protein-G sepharose, using dimethyl pimelimidate 
as described (16). The resulting beads had "~1.5 mg ofmAb bound 
per  milliliter  of wet  beads  and  were  stored  as  a  50%  slurry. 
[3H]LPS  (10  ng/ml;  sp  act  1,000  dpm/ng)  and  40%  normal 
human plasma (NHP) (vol:vol), diluted to a final volume of 200 
#1 in AHPBS (APBS with 5 U/ml heparin), were incubated for 
the stated interval at 37~  160/~1 of the LPS-NHP mixture were 
placed on ice, split into two tubes of 80 #1, mixed with 20/~1 of 
either 26ic or IB4-coupled beads, and incubated for 40 rain at 4~ 
After precipitating the beads by centrifugation  at 2,000 g  for 2 
rain, 90/~1 of supernatant was recovered.  85 ~1 was saved for scin- 
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Figure  1.  Spontaneous  movement of LPS from LPS-sCD14 
complexes  to R-HDL is accelerated  by LBP. LPS-sCD14 com- 
plexes (10 ng/ml and 1/zg/ml, respectively)  were incubated 
for the stated intervals in the absence ([-3, O) or presence 
(30 ng/ml;  O), (100 ng/ml;  A, ,),  of LBP with (O, Q, 
A) or without (U], m) R-HDL (100/zg/ml).  Biologically 
active LPS-sCD14 complexes remaining were assessed by 
adding PMN and by measuring their binding to fibrinogen. 
Each point represents the mean of three wells,  _+  SD of a 
representative experiment repeated three times. 
tillation counting, and the remaining 5/zl were assayed for sCDI4 
by ELISA (1) to confirm that sCD14 had been successfully precipi- 
tated.  The pelleted beads were then washed once with 20 vol of 
AHPBS, eluted with 300/zl of 0.1 M  glycine pH 3.0, and the ra- 
dioactivity in the eluate and the supernatant was evaluated by scin- 
tillation counting in 3 ml of Ready-Safe TM- To assess the biologic 
activity of the LPS-NHP mixtures, CFSE-labeled PMN were added 
to the remaining 40/zl from each time point, incubated for 10 rain 
at 37~  washed,  and evaluated for binding to fibrinogen-coated 
surfaces  as described above. 
Results 
LBP Accelerates the Transfer of LPS from LPS-CD14 Com- 
flexes to R-HDL.  We previously sEowed that LBP catalyzes 
transfer  of LPS from micelles  to  CD14  (3)  and  transfer  of 
LPS from micelles to R-HDL (10). To determine ifLBP also 
catalyzes movement of LPS from LPS-sCD14  complexes to 
R-HDL,  complexes of LPS with  sCD14 were produced by 
incubating  LPS with  a  stoichiometric  excess of sCD14  for 
at  least  5  h  at  37~  As  demonstrated  in  previous  work 
from our laboratory (3), the resulting LPS-sCD14 complexes 
strongly stimulated integrin-mediated adhesion of PMN (Fig. 
1), and stimulation of PMN was not observed unless the LPS 
and sCD14 were precincubated together (not shown).  LPS- 
sCD14  complexes retained  the  capacity  to  stimulate  PMN 
during  incubation  at  37~  for  120  rain  (Fig.  1)  or longer 
(not shown).  However,  addition of R-HDL caused gradual 
loss of the  stimulatory  capacity of LPS-sCD14  complexes. 
R-HDL  thus  "neutralized"  LPS-sCD14  complexes. 
Addition  of low concentrations  of LBP dramatically  ac- 
Figure  2.  Transfer  of [3H]LPS to R-HDL from 
sCD14 is accelerated  by LBP. (A) [3H]LPS  was in- 
cubated for 4 h with buffer (lane 1 ); LBP (1/zg/ml; 
lane 2); or LBP and R.-HDL (100/zg/ml; lane 4). 
[3H]LPS-sCD14 complexes, formed as described 
in Materials and Methods, were run in lane 3. A 
silver stain of R-HDL is shown for comparison 
(lane 5).  (B)  [3H]LPS-sCD14 complexes were 
prepared as described in Materials and Methods, 
diluted to a final concentration of I/zg/ml [3H]LPS 
and 50/zg/ml sCD14, and incubated for the stated 
interval with  buffer  (lane I );  LBP  (1  #g/ml; 
lane 2); Ik-HDL (100/.tg/ml; lanes 3-7); or LBP 
and Ik-HDL  (lanes 8-12), before separation by 
native PAGE. 
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Figure 3.  Low doses of LBP enable  neutralization of LPS- 
sCD14 complexes  by R-HDL LPS-sCD14 complexes, pre- 
pared as described in Materials and Methods and diluted to 
an equivalent of 10 ng/ml of LPS and 1/xg/ml of sCD14, 
were incubated for 30 min with increasing concentrations of 
LBP in the absence (A) or presence (A) of R-HDL (100 
#g/ml). Biologically  active  LPS-sCD14 complexes  remaining 
were assessed  by adding PMN and by measuring their binding 
to fibrinogen. Each point represents the mean of three wells, 
-+ SD of a representative experiment repeated three times. 
celerated neutralization of LPS-sCD14 complexes. 100 ng/ml 
of LBP caused at least a 20-fold enhancement of the neutral- 
ization rate (Fig. 1). By analogy with the finding that LBP 
catalyzes binding and neutralization  of micellar LPS, these 
results suggest that LBP catalyzes  neutralization of  LPS-sCD14 
complexes by catalyzing  the movement of LPS from LPS- 
sCD14 complexes to R-HDL. 
We used 3H-labeled LPS ([3H]LPS) and native PAGE to 
directly examine the transfer of LPS to R-HDL. Preliminary 
studies established the feasibility of this approach. [3H]LPS, 
alone, ran as a high molecular weight aggregate (Fig. 2 A, 
lane I ), while R-HDL, alone, ran in a lower molecular weight 
range, reflecting particles composed of 2, 3, or 4 copies of 
apo A-I (Fig. 2 A, lane 5). Neither LBP (Fig. 2 A, lane 2) 
nor R-HDL (Fig. 7, lanes 1-4) caused a significant change 
in  mobility of [3H]LPS.  However,  incubation  of [3H]LPS 
with LBP and R.-HDL caused the radioactivity to comigrate 
precisely with R-HDL (Fig. 2 A, lane 4). This result demon- 
strates LBP-dependent binding of [3H]LPS to R-HDL  and 
confirms our finding that LBP causes the transfer of LPS to 
R-HDL, as shown previously by ultracentrifugal  separation 
(10). [3H]LPS-sCD14 complexes exhibit high electrophoretic 
mobility and are well separated from R-HDL (Fig. 2 A, lane 
3). Thus, native PAGE resolves miceUar  LPS aggregates, LPS 
bound to R-HDL, and LPS bound to sCD14. 
[3H]LPS-sCD14 complexes were incubated for increasing 
intervals in the presence or absence of LBP and R-HDL and 
were then analyzed on native gels. [3H]LPS-sCD14 com- 
plexes were very stable, with no change in the amount of 
radioactivity or the mobility of [3H]LPS occurring after 100 
rain of incubation at 37~  in the presence or absence of  LBP 
(Fig.  2 B,  lanes I  and 2).  Incubation of [3H]LPS-sCD14 
complexes with R-HDL, however, resulted in a time-depen- 
dent shift of [3H]LPS to a mobility consistent with R-HDL 
(Fig.  2  B,  lanes 3-7).  This  finding  demonstrates  that 
[3H]LPS can move spontaneously from  sCD14  to tL-HDL 
and  is  consistent  with  the  spontaneous  neutralization  of 
LPS-sCD14 complexes observed in Fig. 1. Addition of LBP 
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Figure 4.  LBP enables neutralization of large amounts of 
LPS-sCD14 complexes.  LPS-sCD14 complexes  were formed 
as described in Materials and Methods with a fixed concen- 
tration of sCD14 and increasing  concentrations of  LPS. Com- 
plexes  were diluted to a final sCD14 concentration of I/~g/ml 
and the final LPS concentrations shown in the figure. The 
LPS-sCD14 complexes  were incubated for 30 min in the pres- 
ence of  buffer (Fq), LBP (1 #g/ml; it), R-HDL (100/xg/ml; 
O), or LBP and R-HDL (O), and biologically active LPS- 
sCD14 complexes remaining were assessed  by adding PMN 
and by measuring their binding to fibrinogen. Each point 
represents the mean of three wells, _+ SD of a representative 
experiment repeated twice. during the incubation accelerated the movement of [3H]LPS 
from  [3H]LPS-sCD14  complexes  to  P.-HDL  10-30-fold 
(Fig.  2 B, lanes 8-12).  These results confirm that LBP ac- 
celerates the movement of LPS from LPS-sCD14 complexes 
to P,-HDL and suggest that this movement causes neutral- 
ization of the biological activity of LPS-sCD14 complexes 
by R-HDL (Fig.  1). Quantitative aspects of the neutraliza- 
tion of LPS-sCD14 complexes by R-HDL were explored in 
several assays. 
LBP Acts Catalytically in the Transfer of LPS from LPS- 
sCD14 Complexes to R-HDL.  LPS-sCD14 complexes were 
incubated for 30 min with increasing concentrations of LBP 
in the presence or absence of R-HDL. 30 min was insufficient 
time for significant neutralization of LPS-sCD14 complexes 
by R-HDL alone (Fig.  3). However, low concentrations of 
LBP (10 ng/ml) enabled strong neutralization of the stimula- 
tory capacity of LPS-sCD14 complexes. The amount of LPS- 
sCD14 complexes neutralized by LBP and R-HDL was cal- 
culated from a standard curve relating LPS concentration to 
cell adhesion (data not shown). At a concentration of 10 ng/ml, 
each molecule of LBP enabled the neutralization of at least 
three molecules of LPS by R-HDL. Similarly,  substoichio- 
metric  amounts  of LBP  caused  the  complete  transfer  of 
[3H]LPS from sCD14  to tL-HDL within 10-30  min (Fig. 
2, lanes 8-12). Taken together, these data show that LBP can 
catalytically accelerate the transfer of LPS out of sCD14 into 
P,-HDL. 
LBP Enables Neutralization of Large Amounts LPS-sCD14 
Complexes by Low Concentrations of R-HDL.  LPS-sCD14 
complexes were formed with increasing concentrations of LPS 
and a fixed concentration of sCD14. Complexes containing 
as little as 1 ng/ml of LPS strongly stimulated adhesion of 
PMN (Fig. 4). The stimulatory capacity of these complexes 
was not significantly reduced by incubation with P,-HDL 
for 30 min. However, addition of LBP enabled R-HDL to 
neutralize LPS-sCD14  complexes  formed with up to  100 
ng/ml of LPS. Thus, LBP caused at least a 100-fold increase 
in  the  amount  of LPS-sCD14  complexes  neutralized by 
tL-HDL within 30 min. 
LBP also dramatically reduced the concentration of P,-HDL 
necessary for rapid and complete neutralization of LPS-sCD14 
complexes. In the absence of  LBP, at least 30 #g/ml of R-HDL 
was necessary  to observe  complete neutralization of LPS- 
sCD14 complexes within 60 min (Fig.  5).  However, addi- 
tion of LBP enabled as little as 1/.tg/ml of R-HDL to com- 
pletely neutralize the LPS-sCD14 complexes. Thus, LBP re- 
duced the  concentration of R.-HDL necessary  to  observe 
complete neutralization by ",~30-fold. The data presented 
above provide compelling evidence that LPS moves sponta- 
neously from LPS-sCD14 complexes  to R-HDL, and that 
movement of LPS from sCD14 to R-HDL is catalyzed by LBP. 
sCD14 Acts Cooperatively with LBP in the Transfer of LPS 
to R-HDL.  We have previously demonstrated that LBP can 
directly catalyze the movement of LPS to P,-HDL and thereby 
promote neutralization of LPS (10). The above experiments 
suggest that LBP could enable neutralization of LPS through 
another pathway in which LBP first catalyzes binding of LPS 
to sCD14 and then catalyzes the transfer of LPS from sCD14 
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to R-HDL. To examine whether such a pathway is favored 
over direct transfer of LPS to R-HDL, we compared the rate 
of neutralization of LPS caused by sCD14 and LBP individu- 
ally or in combination, sCD14 alone was ineffective in en- 
abling neutralization of LPS by R-HDL (Fig. 6 B ). This im- 
plies that, for sCD14 to promote neutralization of LPS by 
R-HDL, LPS must first be allowed to bind sCD14. As we 
have shown previously, LBP was effective in enabling the neu- 
tralization of LPS by R.-HDL, with more than half of the 
stimulatory capacity of LPS neutralized within 60 rain (Fig. 
6 A).  However, addition of sCD14 with LBP caused very 
rapid neutralization by R-HDL, with more than half of the 
LPS activity neutralized within 2 rain. This represents  a 30- 
fold increase over the rate of LPS neutralization by P,-HDL 
made possible by LBP alone.  Since sCD14 did not demon- 
strate any ability to enable neutralization of LPS by P,-HDL 
over the time tested (Fig.  6 B), LBP and sCD14 clearly act 
synergistically:  the rate of neutralization observed when LBP 
and sCD14 are combined is much greater than the sum of 
the rates observed with either protein alone. This synergism 
implies that LBP interacts with sCD14 in the rapid neutral- 
ization of LPS and supports the conclusion that LPS can be 
transferred to R-HDL, via sCD14,  in two sequential half- 
reactions catalyzed by LBP: transfer of LPS into sCD14 and 
transfer of LPS out of sCD14 into P,-HDL. 
To  confirm that LBP and sCD14  function together in 
transfer of LPS to  R-HDL,  we used [3H]LPS and native 
PAGE. No spontaneous transfer of [3H]LPS to tL-HDL was 
observed at any time point (Fig. 7, lanes 1-4), nor was sCD14 
able to cause  any transfer of [3H]LPS to R-HDL (Fig.  7, 
lanes 5-8). LBP alone did promote transfer of most of the 
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Figure 5.  LBP enables  neutralization  of LPS-sCD14 complexes  by low 
concentrations  of R-HDL. LPS-sCD14 complexes,  prepared as described 
in Materials  and Methods  and diluted  to a final  concentration  of  0.5/zg/ml 
sCD14 and 10 ng/ml LPS, were incubated for 60 min with increasing 
concentrations of P,-HDL in the absence (O) or presence (O) of LBP 
(1/xg/ml). Biologically  active  LPS-sCD14 complexes  remaining  were as- 
sessed  by their  ability  to stimulate  PMN binding  to fibrinogen.  Each  point 
represents the mean of three wells, ___ SD of a representative experiment 
repeated three times. o4 
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Figure 6.  sCD14 and LBP act cooperatively to en- 
able neutralization  of LPS by R-HDL. (A) LPS (10 
ng/ml) and rLBP (1 #g/ml) were incubated for the 
stated intervals with buffer (O), rsCD14 (1/zg/ml; 
~), RHDL (100/zg/ml; O), or RHDL and sCDI4 
(V). Biologically active LPS remaining was assessed 
by addition  of PMN and by measuring  binding to 
fibrinogen, sCD14 alone is ineffective  in enabling neu- 
tralization of micellar LPS by R-HDL. (/3) LPS (10 
ng/ml) was incubated  for the stated intervals with 
sCD14 (1/xg/ml) in the presence (O) or absence (D) 
of R-HDL (100 #g/ml). Biologically active LPS re- 
maining was assessed by addition of LBP (1/zg/ml) 
and PMN and by measuring binding to fibrinogen. 
Each point represents the mean of three wells, •  SD 
of a representative  experiment repeated three times (A), 
or twice  (B). 
Figure 7.  LBP and sCD14 cooperate in the transfer of LPS to R-HDL. 
[3H]LPS (1 #g/ml) was incubated for the stated intervals with R-HDL 
(100/zg/ml; lane I-4);  sCD14 (1/zg/ml) and R-HDL (lane 5-8); rLBP 
(1/xg/ml)  and R-HDL (lane 9-12), or LBP, sCD14, and R-HDL (before 
separation  by native PAGE;  lane 13-16). The mobility  of LPS-sCD14 com- 
plexes is indicated with an arrowhead. 
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Figure 8.  Concentration-dependent  enhancement 
of LPS neutralization  by sCD14. LPS (10 ng/ml) and 
LBP (1/~g/ml) were incubated  for 30 min with in- 
creasing  concentrations  of rsCD14 in the absence  (O) 
or presence  (Q) of R-HDL (100 #g/ml). Biologically 
active  LPS remaining  was assessed  by addition  of PMN 
and by measuring  binding to fibrinogen.  Each point 
represents the mean of three wells, -+ SD of a repre- 
sentative experiment repeated three times. 
[3H]LPS from high molecular weight micelles  to R-HDL 
within 4  h  of incubation (Fig.  7,  lanes  9-12).  However, 
combining LBP and sCD14  caused  very rapid  transfer of 
[3H]LPS from LPS micelles to R-HDL. Partial  transfer oc- 
curred within 10 min, and complete transfer occurred by I h 
of incubation (Fig.  7, lanes  I3-16).  This rate represents  at 
least a fourfold increase over the rate at which LPS is trans- 
ferred to R-HDL by LBP alone. LPS-sCD14 complexes ap- 
pear to serve as a reaction intermediate in the transfer of LPS 
from micelles to R-HDL in the presence of LBP and sCD14. 
A band corresponding to  [3H]LPS-sCD14 complexes was 
observed at the two earliest time points (Fig. 7, lanes 13 and 
14, arrowhead), but disappeared  at later time points (Fig.  7, 
lanes 15 and 16) after complete transfer of LPS to R-HDL. 
The disappearance of [3H]LPS from the band corresponding 
to LPS-sCD14 represents  transfer of LPS to R-HDL and not 
a shift in the mobility of LPS-sCD14 complexes.  Western 
blot analysis demonstrated that the bands staining with anti- 
CD14 migrated with a high mobility consistent with the 
mobility of sCD14,  both  before  and  after movement of 
[3H]LPS to R-HDL. No sCD14 comigrated with R-HDL 
under any conditions (data not shown). These binding studies 
thus confirm that LBP and sCD14  synergize in the transfer 
of LPS to R-HDL, with LBP first transferring LPS to sCD14 
and subsequently from sCD14 to R-HDL. Several aspects of 
this LPS transfer mechanism were studied in subsequent ex- 
periments. 
Rapid Neutralization of LPS by R-HDL and LBP Is Depen- 
dent on the Concentration of sCD14.  LPS was incubated for 
30 min with increasing concentrations of sCD14 in the pres- 
ence or absence of R-HDL. 30 min was insufficient time for 
LBP to enable significant neutralization of LPS by R-HDL 
(Fig. 8). However, addition of sCD14 enhanced the neutral- 
ization of LPS caused by LBP, with complete neutralization 
occurring in the presence  of 0.3/~g/ml sCD14. 
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LBP and sCD14 Act Synergistically to Enable the Neutraliza- 
tion of  High Concentrations of  LPS by R-HDL.  Increasing con- 
centrations of LPS were incubated for 30 min with LBP in 
the presence or absence of R-HDL and sCD14. Addition of 
R-HDL caused only partial neutralization of 1 ng/ml of LPS 
(Fig. 9). In contrast, combining sCD14 and R-HDL enabled 
complete neutralization of as much as 100 ng/ml of LPS. Thus, 
the addition of sCD14 caused at least a 100-fold increase in 
the amount of LPS that can be neutralized by R-HDL in 
the presence  of LBP. 
Combining LBP and sCD14 reduced the concentration of 
R-HDL necessary to accomplish complete neutralization of 
LPS activity. LBP incubated with high concentrations of 
R-HDL (100/zg/ml) caused  only partial neutralization of 
LPS after 30 rain of incubation (Fig.  10). However, com- 
bining LBP and sCD14 enabled complete neutralization of 
LPS by as little as 10/~g/ml of R-HDL. This is further evi- 
dence that LBP and sCD14 work synergistically to enhance 
the neutralization of LPS by R-HDL. 
sCD14 Carries LPS in a Low Molecular Weight Form.  The 
above results suggest that sCD14 may accelerate the transfer 
of LPS between LPS micelles and R-HDL by acting as a car- 
rier, shuttling LPS between these two sites. To provide evi- 
dence that sCD14 can function as a shuttle for LPS, we mea- 
sured the movement of LPS through 100-kD  cutoff filters. 
LPS in aqueous solutions forms large aggregates,  which mi- 
grate in native PAGE with an apparent tool wt of at least 
500 kD (3). We reasoned that, while LPS in this form could 
not pass through a 100-kD  cutoff ultraftltration membrane, 
LPS in the monomer form (mol wt =5 kD) or bound with 
low stoichiometry to LBP (mol wt =60 kD) or sCD14 (tool 
wt =55 kD), should pass through the membrane. [3H]LPS 
incubated with buffer alone for I h did not exhibit significant 
movement through the membrane (Fig.  11), implying that 
LPS remained in the aggregated form. Incubation of a stoichio- o4 
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Figure  9.  LBP and sCD14 act cooperatively  to en- 
able neutralization  of high concentrations  of LPS. In- 
creasing concentrations  of LPS were incubated  for 30 
rain with LBP (1 #g/ml) in the presence  of  buffer  (O), 
sCD14 (1 #g/ml; A), R-HDL (100/zg/ml; O), or 
sCD14 and R-HDL (A).  Biologically active LPS 
remaining was assessed  by adding  PMN and measuring 
their binding to fibrinogen.  Each  point represents  the 
mean of three wells, _+ SD of a representative  experi- 
ment repeated three times. 
metric  excess  of LBP  or  sCD14  with  [3H]LPS  did  not 
significantly increase the movement of LPS through the filter. 
However, combining LBP and sCD14 caused a 10-fold in- 
crease in the amount of LPS which moved across  the filter. 
The LPS appears to be carried across the membrane in associ- 
ation with sCD14,  rather than LBP, since  ELISAs on the 
ultrafiltrate showed that sCD14 passed readily through the 
100-kD cutoff membrane, both in the presence and absence 
of LPS and LBP, but in no case was LBP, itself, able to cross 
the membrane (data not shown). LBP may, thus, self-associate 
or bind to LPS micelles to form an aggregate with a total 
tool wt >100 kD. These findings demonstrate a shuttle ac- 
tivity for sCD14 that may underlie its role in the neutraliza- 
tion of LPS by R-HDL and LBP. 
LPS Binds  Transiently to sCD14 in Plasma.  LPS binds to 
lipoproteins in plasma and is thereby neutralized (7, 9, 17). 
To determine if LPS-sCD14 complexes are an intermediate 
in  this  process,  [3H]LPS  was  incubated  at  37~  for  in- 
creasing intervals in plasma, then sCD14 was isolated by im- 
munoprecipitation with  an  anti-CD14  mAb.  Binding  of 
[3H]LPS  to sCD14 in plasma occurred rapidly, attaining a 
maximum within 10 rain (Fig. 12 A). Upon further incuba- 
tion at 37~  however, the amount of [3H]LPS bound to 
sCD14 declined markedly. LPS thus binds to and then dis- 
sociates  from sCD14 in plasma,  and this transient interac- 
tion mirrors that observed in mixtures of purified proteins 
(Fig.  7).  It should be noted that maximal specific binding 
of LPS to sCD14 (10 rain; Fig.  12 A) represented only 32% 
of the total LPS recovered (data not shown). The relatively 
low proportion of LPS associated  with sCD14 at any given 
time point may reflect the dynamic process of LPS moving 
into and out of sCD14.  These results suggest that sCD14 
may be an intermediate in the transfer of LPS to lipoproteins 
in plasma. These results do not, however, indicate whether 
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Figure 10.  LBP and sCD14 act cooperatively  to en- 
able neutralization of LPS by low concentrations  of 
R-HDL. LPS (10 ng/ml) and LBP (1 #g/ml) were  in- 
cubated for 30 rain with increasing  concentrations  of 
R-HDL  in the absence  (O) or presence  (Q) of  sCD14 
(1 #g/ml). Biologically  active  LPS remaining was as- 
sessed by adding PMN and measuring binding to fibri- 
nogen. Each point represents  the mean  of  three  wells, 
_+ SD of a representative  experiment repeated three 
times. 0.. 
O 
2000 
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m  m 
BUFFER  LBP  sCD14  LBP + sCD14 
Figure  11.  sCD14  carries LPS across a lO0-kD cutoff 
ultrafi]tration membrane. [3H]LPS (10 ng/ml) was in- 
cubated for 60 min at 37~  with buffer alone, LBP 
(1 #g/ml), sCD14 (1/~g/ml), or LBP and sCD14, and 
subjected to ultrafiltration  through a 100-kD cutoff 
membrane.  The radioactivity  in the ultrafiltrate  was 
measured by scintillation counting. Under these con- 
ditions,  in the presence of LBP and sCD14,  '~25% 
the total cpm added to the filter were recovered in the 
ultrafdtrate. Each bar represents the mean of two counts 
of a representative experiment  repeated  twice. 
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Figure  12.  [3H]LPS binds  transiently  to  plasma 
sCD14.  [3H]LPS (10  ng/ml)  was  incubated  with 
NHP (40%) for the stated intervals at 37~  (.4) The 
amount of [3H]LPS specifically bound to sCD14 was 
determined  by immunoprecipitation of the mixture 
with either an anti-CD14  (O; 26ic), or a control (O; 
IB4) mAb. The values represent the number of cpm 
found in the immunoprecipitate  from a representative 
experiment  repeated  three  times.  (B)  Biologic ac- 
tivity of the LPS-NHP mixtures was assessed by ad- 
dition of PMN for 10 min, washing,  and measuring 
binding of cells to fibrinogen-coated surfaces (O). Nei- 
ther LPS alone (O), nor NHP alone (￿9  stimulated 
cell adhesion over background.  Values represent  the 
mean of three wells,  _+ SD of a representative experi- 
ment repeated three  times. Figure 13.  LPS transfer reactions catalyzed  by LBP. See text for details. 
all the LPS transferred  to lipoproteins in plasma passes through 
sCD14. Alternative pathways for transfer of LPS to lipopro- 
teins  may also exist. 
Parallel  studies measured the capacity of LPS-NHP mix- 
tures to stimulate PMN. In keeping with our previous work 
(10),  plasma rapidly enabled LPS to stimulate cells, and fur- 
ther incubation resulted in a loss of the stimulatory capacity 
(Fig.  12 B).  The  rapid  rise and  subsequent fall  in the bio- 
logic potency of LPS-NHP mixtures  corresponded  closely 
with the rapid binding and gradual dissociation of LPS and 
sCD14. These results suggest that LPS-sCD14 complexes rep- 
resent a key intermediate in cellular responses to LPS and that 
dissociation  of LPS from sCD14 is required  for neutraliza- 
tion  of the LPS. 
Discussion 
Previous work from our laboratory has shown that LBP 
catalyzes two distinct reactions: transfer of LPS from micelles 
to CD14  (3)  and transfer of LPS from micelles to R-HDL 
particles (10). Here we demonstrate that LBP facilitates a third 
reaction:  transfer  of LPS  from  LPS-CD14  complexes  to 
R-HDL  (Fig.  13).  As in  the previously characterized  LPS 
transfer reactions, LBP acts catalytically to enable the move- 
ment of LPS from CD14 to R-HDL, with each LBP mole- 
cule enabling  the movement of at least three molecules of 
LPS within  30 min (Fig.  3).  The catalytic action of LBP is 
consistent with its structural  similarity to cholesterol ester 
transfer protein (CETP)  (2)  and phospholipid transfer pro- 
tein (PLTP) (18), plasma proteins with well-characterized ca- 
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pacity to facilitate the movement of lipids between lipopro- 
rein particles  (19,  20). 
An inspection of the three reactions catalyzed by LBP re- 
veals two possible paths by which micellar LPS may be trans- 
ferred  to IK-HDL:  direct  transfer  (reaction  1,  Fig.  13) and 
indirect transfer via sCD14 (reactions 2 and 3, Fig. 13). Here 
we show that,  under  our experimental  conditions,  the in- 
direct pathway is kinetically favored. Addition of sCD14 to 
LBP enhanced the rate of transfer of LPS to R-HDL (Figs. 
6 A  and 7), increased the amount of LPS that could be neu- 
tralized by a fixed dose of R-HDL in a fixed time (Fig.  9), 
and decreased the amount  of R-HDL needed to neutralize 
a fixed dose of LPS in  a fixed time  (Fig.  10).  Since sCD14 
demonstrated no ability to transfer micellar LPS on its own 
(Fig.  6 B), these results suggest that LBP and sCD14 work 
synergistically to  transfer  LPS to  1K-HDL. 
sCD14 may enhance the LBP-mediated transfer of LPS to 
R-HDL by shuttling LPS between LPS micelles and R-HDL. 
Our previous work showed that LBP transfers  a single mole- 
cule of LPS to sCD14 (3).  Here we have shown that LPS- 
sCD14  complexes formed from  this  reaction  are diffusible 
across a  100-kD cutoff filter  (Fig.  11). We further  showed 
that LPS-sCD14 complexes donate their LPS to R-HDL in 
a transfer reaction that is catalyzed by LBP (Fig.  1). A role 
for LPS-sCD14 complexes as intermediate carriers of LPS was 
confirmed by the observation that these complexes are tran- 
siently formed in the movement from LPS micelles to R-HDL 
facilitated by LBP and  sCD14  (Fig.  7).  A  requirement  for 
an intermediate carrier is suggested by the fact that LBP does 
not exhibit the properties of an effective shuttle.  It binds tightly 
to bacteria or LPS-coated surfaces  (21,  22), it fails to move 
LPS across  a  100-kD cutoff filter (Fig.  11), and it is found 
in  plasma  associated with  HDL particles  (10).  The  use of 
sCD14  as  a  mobile carrier  protein  supplants  the  need  for 
diffusion of LPS-LBP or LBP-HDL complexes and accelerates 
the transfer of LPS between these two complexes.  The finding 
that LBP can use a soluble carrier protein (sCD14) to effect 
LPS transport raises the possibility that CETP or PLTP may 
use sCD14 or a related  shuttle protein  to equilibrate lipids 
among  lipoprotein  particles. 
The capacity of LPS-sCD14 complexes to donate LPS to 
R-HDL suggests a role for sCD14 in the trafficking of LPS 
to lipoproteins  in plasma.  We have previously shown  that 
incubation of LPS with plasma for brief intervals enables strong 
stimulation of PMN (10). This stimulation of PMN is likely 
to represent the action of LPS-sCD14 complexes, since these 
complexes form rapidly in the presence of LBP (3) and upon 
incubation of LPS with plasma (Fig.  12), and are known to 
stimulate endothelial cells (1, 3), PMN (3, 4), and astrocytes 
(1,  23).  Further  incubation  of LPS with plasma,  however, 
results in neutralization  of LPS,  with  nearly complete loss 
of biological activity after 2 h. This neutralization is known 
to represent  the movement of LPS to lipoprotein  particles 
(5-7, 24), and, here, we show that neutralization is temporally 
correlated with loss of LPS from sCD14 (Fig. 12). These results 
suggest  that  neutralization  of LPS  in  plasma  may  occur 
through  transfer of LPS from LPS-sCD14 complexes to li- 
poprotein  particles. 
Shuttle We have observed  that LBP-catalyzed movement of LPS 
to sCD14 (Fig. 13, reaction 2) occurs much more rapidly than 
LBP-catalyzed movement of LPS into R-HDL (Fig. 13, reac- 
tion I ) (see Fig. 7 and reference 3). Under conditions in which 
sCD14 and HDL are in excess, such as those in plasma (25), 
movement of LPS to sCD14, and, thus, formation of LPS- 
sCD14 complexes, should be favored. Furthermore, the prev- 
alence of LPS-sCD14 complexes will be dictated by the rela- 
tive rates of LPS movement into sCD14 (reaction 2) and LPS 
movement out of sCD14 to lipoproteins (reaction 3). If reac- 
tion 2 is faster than 3, LPS-sCD14 complexes will accumu- 
late and cell stimulation will be observed.  Conversely, if re- 
action 3 is faster  than 2,  few LPS-sCD14 complexes  will 
accumulate, and the LPS will be rapidly neutralized. Con- 
trol of these two rates may thus yield a sensitive means of 
regulating responsiveness  of mammals to LPS. 
We also wish to emphasize that the effectiveness of sCD14 
as a shuttle for LPS depends on the relative rates of reactions 
1 and 3 in Fig.  13. If reaction 3 is faster than 1, then sCD14 
may hasten neutralization of LPS by shuttling LPS to HDL, 
as we have found here with R-HDL particles.  On the other 
hand, if reaction I is faster than 3, then sCD14 could impede 
movement of LPS to HDL by diverting the LPS from reac- 
tion 1.  Reactions 1 and 3 involve not only LPS, LBP, and 
sCD14, but also a lipoprotein particle,  and the nature of that 
lipoprotein particle may affect transfer rates. We have observed 
that the RoHDL particles  used here rapidly neutralize LPS 
in the presence of LBP and sCD14 (Fig. 6), but that plasma 
(Fig.  12 B) and native HDL particles  (M. M.  Wurfel and 
S. D. Wright, unpublished observations) neutralize LPS much 
more slowly under similar conditions. Since plasma contains 
a wide spectrum of lipoprotein particles, our experiments do 
not predict whether sCD14 will hasten or slow the neutral- 
ization of LPS in plasma. The kinetics of LPS transfer reac- 
tions in whole plasma is now under study. 
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